Search

Your search keyword '"Ciesla-Dul M."' showing total 15 results

Search Constraints

Start Over You searched for: Author "Ciesla-Dul M." Remove constraint Author: "Ciesla-Dul M."
15 results on '"Ciesla-Dul M."'

Search Results

2. Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on Atrial Fibrillation

3. Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation

4. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The euro heart survey

5. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The Euro Heart Survey on atrial fibrillation

6. Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart

7. Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation

8. Atrial fibrillation management: A prospective survey in ESC Member Countries - The Euro Heart Survey on atrial fibrillation

9. A vitamin K epoxide reductase-oxidase complex gene polymorphism (-1639GA) and interindividual variability in the dose-effect of vitamin K antagonists

11. Gender-Related Differences in Presentation, Treatment, and Outcome of Patients With Atrial Fibrillation in Europe. A Report From the Euro Heart Survey on Atrial Fibrillation

12. Fibrin clot properties in women heterozygous for factor V Leiden mutation: effects of oral contraceptives.

13. Effects of atorvastatin on plasma fibrin clot properties in apparently healthy individuals and patients with previous venous thromboembolism.

14. Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives.

15. A vitamin K epoxide reductase-oxidase complex gene polymorphism (-1639G>A) and interindividual variability in the dose-effect of vitamin K antagonists.

Catalog

Books, media, physical & digital resources